|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 369351-369375 of 2303212 (92129 Page(s) Totally)
<< < 14770 14771 14772 14773 14774 14775 14776 14777 14778 14779 > >>
View [10|25|50] records per page
| 義守大學 |
2018-11 |
Efficacy of ϕkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection
|
Jiun-Ling Wang;Chih-Feng Kuo;Che-Ming Yeh;Jung-Ren Chen;Ming-Fang Cheng;Chih-Hsin Hung |
| 國立成功大學 |
2018 |
Efficacy of ϕkm18p phage therapy in a murine model of extensively drug-resistant Acinetobacter baumannii infection
|
Wang, J.-L.;Kuo, C.-F.;Yeh, C.-M.;Chen, J.-R.;Cheng, M.-F.;Hung, C.-H. |
| 中山醫學大學 |
2020 |
Efficacy Outcomes Following Etanercept Withdrawal by Sustained Remission Status in Patients with Nr-axSpA: Results from RE-EMBARK
|
van den Bosch, F; Nash, P; Wei, JCC; Blanco, F; Tsekouras, V; Zang, CB; Graham, D; Arthur, E; Selema, P; Vlahos, B; Deodhar, A |
| 國立臺灣大學 |
2003-07-11 |
Efficacy safety and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease
|
Wong Ka-Sing; Lu Chin-Song; Shan Din-E; Yang Chih-Chao; Tsoi Tak-Hong; Mok Vincent |
| 國立交通大學 |
2014-12-08T15:28:10Z |
Efficacy verification and microscopic observations of an anticancer peptide, CB1a, on single lung cancer cell
|
Kao, Feng-Sheng; Pan, Yun-Ru; Hsu, Ray-Quen; Chen, Hueih-Min |
| 臺大學術典藏 |
2019-02-19T06:40:03Z |
Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries
|
Luxembourg, A;Perez, G;Walia, A;Shields, C;Sawata, M;Ritter, M;Murata, S;Moeller, E;Han, S R;Ellison, M C;Yoshikawa, H;Bhatla, N;Ryu, H-S;Sakamoto, M;Kang, J-H;Lalwani, S;Song, Y-S;Kim, K-H;Kim, Y-T;Kim, B-G;Huang, L-M;Kim, S C;Cheung, T H;Takeuchi, Y;Samakoses, R;Twu, N-F;Chu, T-Y;Yang, Y C;Lee, C-Y;Cho, C-H;Ngan, H Y S;Pitisuttithum, P;Garland, S M;CHEN, CHI-AN; Garland, S M; Pitisuttithum, P; Ngan, H Y S; Cho, C-H; Lee, C-Y; CHEN, CHI-AN; Yang, Y C; Chu, T-Y; Twu, N-F; Samakoses, R; Takeuchi, Y; Cheung, T H; Kim, S C; Huang, L-M; Kim, B-G; Kim, Y-T; Kim, K-H; Song, Y-S; Lalwani, S; Kang, J-H; Sakamoto, M; Ryu, H-S; Bhatla, N; Yoshikawa, H; Ellison, M C; Han, S R; Moeller, E; Murata, S; Ritter, M; Sawata, M; Shields, C; Walia, A; Perez, G; Luxembourg, A |
| 臺大學術典藏 |
2020-01-22T07:50:24Z |
Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants from Asian Countries
|
Garland S.M.;Pitisuttithum P.;Ngan H.Y.S.;Cho C.-H.;Lee C.-Y.;Chi-An Chen;Yang Y.C.;Chu T.-Y.;Twu N.-F.;Samakoses R.;Takeuchi Y.;Cheung T.H.;Kim S.C.;Huang L.-M.;Kim B.-G.;Kim Y.-T.;Kim K.-H.;Song Y.-S.;Lalwani S.;Kang J.-H.;Sakamoto M.;Ryu H.-S.;Bhatla N.;Yoshikawa H.;Ellison M.C.;Han S.R.;Moeller E.;Murata S.;Ritter M.;Sawata M.;Shields C.;Walia A.;Perez G.;Luxembourg A.; Garland S.M.; Pitisuttithum P.; Ngan H.Y.S.; Cho C.-H.; Lee C.-Y.; CHI-AN CHEN; Yang Y.C.; Chu T.-Y.; Twu N.-F.; Samakoses R.; Takeuchi Y.; Cheung T.H.; Kim S.C.; Huang L.-M.; Kim B.-G.; Kim Y.-T.; Kim K.-H.; Song Y.-S.; Lalwani S.; Kang J.-H.; Sakamoto M.; Ryu H.-S.; Bhatla N.; Yoshikawa H.; Ellison M.C.; Han S.R.; Moeller E.; Murata S.; Ritter M.; Sawata M.; Shields C.; Walia A.; Perez G.; Luxembourg A. |
| 臺大學術典藏 |
2021-06-24T07:16:15Z |
Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants from Asian Countries
|
Garland S.M.; Pitisuttithum P.; Ngan H.Y.S.; Cho C.-H.; Lee C.-Y.; Chen C.-A.; Yang Y.C.; Chu T.-Y.; Twu N.-F.; Samakoses R.; Takeuchi Y.; Cheung T.H.; Kim S.C.; LI-MIN HUANG; Kim B.-G.; Kim Y.-T.; Kim K.-H.; Song Y.-S.; Lalwani S.; Kang J.-H.; Sakamoto M.; Ryu H.-S.; Bhatla N.; Yoshikawa H.; Ellison M.C.; Han S.R.; Moeller E.; Murata S.; Ritter M.; Sawata M.; Shields C.; Walia A.; Perez G.; Luxembourg A. |
| 國立臺灣大學 |
2010 |
Efficacy, Patient Satisfaction and Adherence to Treatment with Deferasirox Doses of=30 Mg/Kg/Day in Previously Chelated Iron-Overloaded Patients with Beta-Thalassaemia Major
|
林凱信; LIN, KAI-HSIN |
| 臺北醫學大學 |
2017 |
Efficacy, Safety and Healthcare Cost among Patients Newly Treated with New Oral Anticoagulants and Warfarin
|
Cheng, Zih-Yi; 鄭紫誼 |
| 國立臺灣大學 |
2016 |
Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study
|
Ye, D.; Ahn, H.; Pu, Y-S.; Han, W.; Xie, L-P.; Huang, S-P.; Wu, H-C.; Ma, L.; Qi, J.; Zhou, F.; Sun, G.; Chen, L.; Xue, B.; Yamada, S.; Saito, M.; Suga, K.; Sun, Y.; 蒲永孝 |
| 國立臺灣大學 |
2011 |
Efficacy, Safety and Tolerability of Fesoterodine in Asian Patients with Overactive Bladder
|
林鶴雄; LIN, HO-HSIUNG |
| 臺大學術典藏 |
2018-09-10T08:50:19Z |
Efficacy, safety and tolerability of fesoterodine in asian patients with overactive bladder
|
Yamaguchi, O. and Nishizawa, O. and Takeda, M. and Yoshida, M. and Choo, M.-S. and Gu Lee, J. and Tong-Long Lin, A. and Lin, H.-H. and Andrew Yip, W.-C. and Isowa, H. and Hiro, S.; HO-HSIUNG LIN |
| 臺大學術典藏 |
2020-02-17T08:51:00Z |
Efficacy, safety and tolerability of fesoterodine in asian patients with overactive bladder
|
Yamaguchi O; Nishizawa O; Takeda M; Yoshida M; Choo M.-S; Gu Lee J; Tong-Long Lin A; HO-HSIUNG LIN; Andrew Yip W.-C; Isowa H; Hiro S. |
| 臺大學術典藏 |
2021-03-03T03:01:10Z |
Efficacy, safety and tolerability of fesoterodine in asian patients with overactive bladder
|
Yamaguchi O.;Nishizawa O.;Takeda M.;Yoshida M.;Choo M.-S.;Gu Lee J.;Tong-Long Lin A.;Ho-Hsiung Lin;Andrew Yip W.-C.;Isowa H.;Hiro S.; Yamaguchi O.; Nishizawa O.; Takeda M.; Yoshida M.; Choo M.-S.; Gu Lee J.; Tong-Long Lin A.; HO-HSIUNG LIN; Andrew Yip W.-C.; Isowa H.; Hiro S. |
| 臺大學術典藏 |
2020-12-28T10:02:44Z |
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: An open-label, randomized clinical trial
|
CHIH-CHIEH YU; Lai W.-T.; Shih K.-C.; Lin T.-H.; Lu C.-H.; Lai H.-J.; Hanson M.E.; Hwang J.-J. |
| 臺大學術典藏 |
2020-12-28T12:04:10Z |
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: An open-label, randomized clinical trial
|
HWANG, JUEY-JEN; Hanson M.E.; Lai H.-J.; Yu C.-C.; Lai W.-T.; Shih K.-C.; Lin T.-H.; Lu C.-H. |
| 臺大學術典藏 |
2021-09-09T07:52:48Z |
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: An open-label, randomized clinical trial
|
CHIH-CHIEH YU; Lai W.-T.; Shih K.-C.; Lin T.-H.; Lu C.-H.; Lai H.-J.; Hanson M.E.; Hwang J.-J. |
| 臺大學術典藏 |
2022-09-19T08:13:51Z |
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: an open-label, randomized clinical trial
|
CHIH-CHIEH YU; Lai, Wen-Ter; Shih, Kuang-Chung; Lin, Tsung-Hsien; Lu, Chieh-Hua; Lai, Hung-Jen; Hanson, Mary E; HWANG, JUEY-JEN |
| 臺大學術典藏 |
2022-09-20T06:49:29Z |
Efficacy, safety and tolerability of ongoing statin plus ezetimibe versus doubling the ongoing statin dose in hypercholesterolemic Taiwanese patients: An open-label, randomized clinical trial
|
Yu C.-C.; Lai W.-T.; Shih K.-C.; Lin T.-H.; Lu C.-H.; Lai H.-J.; Hanson M.E.; HWANG, JUEY-JEN |
| 淡江大學 |
2023-01-05 |
Efficacy, safety, and cost of mobilization strategies in multiple myeloma: a prospective, observational study
|
Mau, Lih-wen |
| 臺大學術典藏 |
2021-02-05T06:29:19Z |
Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes
|
Wen-Chien Chou;Yeh S.-P.;Hsiao L.-T.;Lin S.-F.;Chen Y.-C.;Chen T.-Y.;Laille E.;Galettis A.;Dong Q.;Songer S.;Beach C.L.; WEN-CHIEN CHOU; Yeh S.-P.; Hsiao L.-T.; Lin S.-F.; Chen Y.-C.; Chen T.-Y.; Laille E.; Galettis A.; Dong Q.; Songer S.; Beach C.L. |
| 國立成功大學 |
2017 |
Efficacy, safety, and pharmacokinetics of subcutaneous azacitidine in Taiwanese patients with higher-risk myelodysplastic syndromes
|
Chou, W.-C.;Yeh, S.-P.;Hsiao, L.-T.;Lin, S.-F.;Chen, Y.-C.;Chen, T.-Y.;Laille, E.;Galettis, A.;Dong, Q.;Songer, Songer S.;Beach, C.L. |
| 臺大學術典藏 |
2022-08-19T00:20:58Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
Shao Y.-Y.; Lin Z.-Z.; CHIUN HSU; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-05-25T06:51:58Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
Cheng A.-L.;Hsu C.-H;Shen Y.-C;Huang C.-C;Yen-Shen Lu;Hsiao C.-H;Lee K.-D;Hsu C;Lin Z.-Z;Shao Y.-Y; Shao Y.-Y; Lin Z.-Z; Hsu C; Lee K.-D; Hsiao C.-H; YEN-SHEN LU; Huang C.-C; Shen Y.-C; Hsu C.-H; Cheng A.-L. |
Showing items 369351-369375 of 2303212 (92129 Page(s) Totally)
<< < 14770 14771 14772 14773 14774 14775 14776 14777 14778 14779 > >>
View [10|25|50] records per page
|
